Company Seeks Additional Capital Amid Earnings Decline Struggling with declining earnings and sales, the company is in advanced talks with lenders for additional capital. Discover the latest in financing strategies.
Anavex Life Sciences Reports Q4 Loss of $11.6 Million Anavex Life Sciences Corp. posted a fiscal Q4 loss of $11.6 million, translating to 14 cents per share. Explore the impacts on the healthcare sector.
Anavex Life Sciences Reports Narrowed Annual Loss Despite Q4 Setback Anavex Life Sciences narrows annual loss to $43 million despite a Q4 loss of $11.6 million. Stock down over 7% this year. Explore more on their financial performance.
Ennis Inc. Reports $10.2 Million Q3 Earnings Ennis Inc. (EBF) announced robust financial results with earnings reaching $10.2 million in its fiscal third quarter. Discover the details of Ennis' performance.
Ennis Inc. Reports Strong Q3 Earnings of $10.2 Million Ennis Inc. (EBF) posts robust fiscal Q3 earnings of $10.2 million, translating to 39 cents per share, driven by $99.8 million in revenue. Discover more insights here.